Liz Pellicano is professor of autism at University College London in the United Kingdom
Liz Pellicano
Director, Centre for Research in Autism and Education
University College London
From this contributor
We need better strategies to support autistic people as the COVID-19 crisis continues
Interviews with autistic people reveal that many miss their friends and opportunities for social connection, in stark contrast to orthodox views that they have little social motivation and prefer a life of self-isolation.
We need better strategies to support autistic people as the COVID-19 crisis continues
By
Liz Pellicano
8 September 2020 | 6 min read
General practitioners urgently need autism training
Many general practitioners in the United Kingdom do not receive autism training, and report having little confidence in caring for patients on the spectrum.
General practitioners urgently need autism training
By
Laura Crane, Liz Pellicano, The Conversation
17 May 2017 | 5 min read
Friendships pose unique challenges for women on the spectrum
Women with autism value friendships as much as their neurotypical peers do, but they often have difficulty forming and maintaining them.
Friendships pose unique challenges for women on the spectrum
By
Liz Pellicano, Felicity Sedgewick
16 May 2017 | 6 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read